Teleflex Incorporated (TFX)
NYSE: TFX · Real-Time Price · USD
121.09
-1.87 (-1.52%)
At close: May 28, 2025, 4:00 PM
121.09
0.00 (0.00%)
After-hours: May 28, 2025, 4:16 PM EDT
Teleflex Revenue
Teleflex had revenue of $700.67M in the quarter ending March 30, 2025, a decrease of -5.04%. This brings the company's revenue in the last twelve months to $3.01B, up 0.29% year-over-year. In the year 2024, Teleflex had annual revenue of $3.05B with 2.45% growth.
Revenue (ttm)
$3.01B
Revenue Growth
+0.29%
P/S Ratio
1.90
Revenue / Employee
$213,485
Employees
14,100
Market Cap
5.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.05B | 72.84M | 2.45% |
| Dec 31, 2023 | 2.97B | 183.45M | 6.57% |
| Dec 31, 2022 | 2.79B | -18.52M | -0.66% |
| Dec 31, 2021 | 2.81B | 272.41M | 10.74% |
| Dec 31, 2020 | 2.54B | -58.21M | -2.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
TFX News
- 9 days ago - Teleflex Publishes 2024 Global Impact Report - GlobeNewsWire
- 13 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 13 days ago - Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 14 days ago - Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 15 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Shareholders to Inquire about Securities Investigation - Accesswire
- 15 days ago - New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy - GlobeNewsWire
- 16 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Shareholders to Connect - Accesswire
- 16 days ago - Teleflex Announces Quarterly Dividend - GlobeNewsWire